Sermorelin is currently used clinically to assess growth hormone secretion, but the peptide is of additional interest for its abilities to: Reduce scarring following a heart attack, increased bone density, improve nutrition and chronic illness, improve renal function, but the effects of dementia, and reduce seizure activity
The primary antibodies used were ACSL4(1:10000, 22401, China), LPCAT3 (1:6000, 67882, China), and -actin (1:3000, WL01372, China)
Depending on your treatment plan, you can expect the process to be complete in under 20 minutes
It is worth emphasizing that many of these reported effects may reflect the injection process itself, product impurities, or placebo/nocebo phenomena rather than a direct pharmacological action of the peptide
doi: 10.3390/ijms22073603 92 Fratta PasiniA
Bioengineered skin organoids: from development to applications